Montecito Bank & Trust purchased a new position in shares of UnitedHealth Group Inc (NYSE:UNH) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,413 shares of the healthcare conglomerate’s stock, valued at approximately $376,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. Welch Group LLC acquired a new position in UnitedHealth Group during the second quarter worth approximately $106,000. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group during the second quarter worth approximately $107,000. Northwest Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the second quarter worth approximately $117,000. Fort L.P. bought a new stake in shares of UnitedHealth Group during the second quarter worth approximately $119,000. Finally, Stelac Advisory Services LLC bought a new stake in shares of UnitedHealth Group during the first quarter worth approximately $163,000. 85.35% of the stock is currently owned by hedge funds and other institutional investors.

Shares of UNH stock opened at $259.61 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.75 and a quick ratio of 0.75. The company has a market capitalization of $256.06 billion, a P/E ratio of 25.78, a P/E/G ratio of 1.58 and a beta of 0.73. UnitedHealth Group Inc has a 1 year low of $186.00 and a 1 year high of $272.07.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.04 by $0.10. The business had revenue of $56.09 billion during the quarter, compared to analysts’ expectations of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The firm’s revenue for the quarter was up 12.1% compared to the same quarter last year. During the same period in the previous year, the company posted $2.46 earnings per share. As a group, analysts predict that UnitedHealth Group Inc will post 12.72 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 18th. Investors of record on Friday, September 7th were paid a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 1.39%. The ex-dividend date was Thursday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.75%.

A number of equities research analysts have recently issued reports on UNH shares. Citigroup cut UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price objective for the company. in a report on Monday, September 10th. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 18th. Raymond James boosted their price objective on UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a report on Monday, September 24th. Morgan Stanley boosted their price objective on UnitedHealth Group from $278.00 to $305.00 and gave the stock an “overweight” rating in a report on Wednesday, September 5th. Finally, ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 11th. One investment analyst has rated the stock with a hold rating, twenty-two have given a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $278.61.

In related news, EVP D Ellen Wilson sold 15,393 shares of the business’s stock in a transaction that occurred on Friday, August 24th. The stock was sold at an average price of $264.29, for a total value of $4,068,215.97. Following the completion of the sale, the executive vice president now directly owns 66,402 shares in the company, valued at $17,549,384.58. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Kenneth Irwin Shine sold 177 shares of the business’s stock in a transaction that occurred on Wednesday, July 18th. The shares were sold at an average price of $255.72, for a total value of $45,262.44. Following the completion of the sale, the director now owns 29,053 shares of the company’s stock, valued at $7,429,433.16. The disclosure for this sale can be found here. Over the last quarter, insiders sold 94,745 shares of company stock valued at $24,995,290. 0.87% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: Price to Earnings Ratio (PE) Basics

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.